CutisPharma: CutisPharma Announces Acquisition of Silvergate Pharmaceuticals Name Change to Azurity Pharmaceuticals
CutisPharma Inc. announced today its acquisition of Silvergate Pharmaceuticals Inc. and the unveiling of its new corporate brand for the unified company Azurity Pharmaceuticals. I am thrilled to announce the combination...
Read full article »
CutisPharma develops and commercializes proprietary drugs and pharmaceutical products for the prescription compounding sector.
Read more